These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 22308041

  • 1. Absence of acute inhibitory effect of insulin on chylomicron production in type 2 diabetes.
    Nogueira JP, Maraninchi M, Béliard S, Padilla N, Duvillard L, Mancini J, Nicolay A, Xiao C, Vialettes B, Lewis GF, Valéro R.
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1039-44. PubMed ID: 22308041
    [Abstract] [Full Text] [Related]

  • 2. Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans.
    Padilla N, Maraninchi M, Béliard S, Berthet B, Nogueira JP, Wolff E, Nicolay A, Bégu A, Dubois N, Grangeot R, Mattei C, Vialettes B, Xiao C, Lewis GF, Valéro R.
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2330-7. PubMed ID: 25104797
    [Abstract] [Full Text] [Related]

  • 3. Effect of an acute hyperinsulinaemic clamp on post-prandial lipaemia in subjects with insulin resistance.
    Allister EM, James AP, Watts GF, Barrett PH, Mamo JC.
    Eur J Clin Invest; 2006 Jul; 36(7):489-96. PubMed ID: 16796606
    [Abstract] [Full Text] [Related]

  • 4. The effect of high-dose sodium salicylate on chronically elevated plasma nonesterified fatty acid-induced insulin resistance and β-cell dysfunction in overweight and obese nondiabetic men.
    Xiao C, Giacca A, Lewis GF.
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1205-11. PubMed ID: 19755670
    [Abstract] [Full Text] [Related]

  • 5. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G, De Natale C, Iovine C, Patti L, Di Marino L, Coppola S, Del Prato S, Riccardi G, Rivellese AA.
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [Abstract] [Full Text] [Related]

  • 6. Intravenous Glucose Acutely Stimulates Intestinal Lipoprotein Secretion in Healthy Humans.
    Xiao C, Dash S, Morgantini C, Lewis GF.
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1457-63. PubMed ID: 27150393
    [Abstract] [Full Text] [Related]

  • 7. Effects of Intranasal Insulin on Triglyceride-Rich Lipoprotein Particle Production in Healthy Men.
    Xiao C, Dash S, Stahel P, Lewis GF.
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1776-1781. PubMed ID: 28751575
    [Abstract] [Full Text] [Related]

  • 8. High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men.
    Dash S, Xiao C, Morgantini C, Szeto L, Lewis GF.
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2895-901. PubMed ID: 24072699
    [Abstract] [Full Text] [Related]

  • 9. Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production.
    Duez H, Lamarche B, Uffelman KD, Valéro R, Szeto L, Lemieux S, Cohn JS, Lewis GF.
    J Clin Endocrinol Metab; 2008 May; 93(5):1722-9. PubMed ID: 18285418
    [Abstract] [Full Text] [Related]

  • 10. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans.
    Duez H, Lamarche B, Uffelman KD, Valero R, Cohn JS, Lewis GF.
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1357-63. PubMed ID: 16614317
    [Abstract] [Full Text] [Related]

  • 11. Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans.
    Duez H, Lamarche B, Valéro R, Pavlic M, Proctor S, Xiao C, Szeto L, Patterson BW, Lewis GF.
    Circulation; 2008 May 06; 117(18):2369-76. PubMed ID: 18443237
    [Abstract] [Full Text] [Related]

  • 12. Novel role of enteral monosaccharides in intestinal lipoprotein production in healthy humans.
    Xiao C, Dash S, Morgantini C, Lewis GF.
    Arterioscler Thromb Vasc Biol; 2013 May 06; 33(5):1056-62. PubMed ID: 23471231
    [Abstract] [Full Text] [Related]

  • 13. Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats.
    Chirieac DV, Collins HL, Cianci J, Sparks JD, Sparks CE.
    Am J Physiol Endocrinol Metab; 2004 Jul 06; 287(1):E42-9. PubMed ID: 14970003
    [Abstract] [Full Text] [Related]

  • 14. Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans.
    Xiao C, Bandsma RH, Dash S, Szeto L, Lewis GF.
    Arterioscler Thromb Vasc Biol; 2012 Jun 06; 32(6):1513-9. PubMed ID: 22492091
    [Abstract] [Full Text] [Related]

  • 15. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
    Cummings MH, Watts GF, Umpleby AM, Hennessy TR, Kelly JM, Jackson NC, Sönksen PH.
    Diabetes; 1995 Sep 06; 44(9):1059-65. PubMed ID: 7657029
    [Abstract] [Full Text] [Related]

  • 16. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U.
    Exp Clin Endocrinol Diabetes; 2003 Aug 06; 111(5):246-50. PubMed ID: 12951628
    [Abstract] [Full Text] [Related]

  • 17. Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids.
    Pavlic M, Xiao C, Szeto L, Patterson BW, Lewis GF.
    Diabetes; 2010 Mar 06; 59(3):580-7. PubMed ID: 20028946
    [Abstract] [Full Text] [Related]

  • 18. New and emerging regulators of intestinal lipoprotein secretion.
    Xiao C, Dash S, Morgantini C, Lewis GF.
    Atherosclerosis; 2014 Apr 06; 233(2):608-615. PubMed ID: 24534456
    [Abstract] [Full Text] [Related]

  • 19. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans.
    Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G.
    J Clin Invest; 1995 Jan 06; 95(1):158-66. PubMed ID: 7814610
    [Abstract] [Full Text] [Related]

  • 20. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
    Taggart C, Gibney J, Owens D, Collins P, Johnson A, Tomkin GH.
    Diabet Med; 1997 Dec 06; 14(12):1051-8. PubMed ID: 9455933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.